REPONEX PHARMACEUTICALS A/S: Financial statements 2021
CVR: 30082346
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
REPONEX PHARMACEUTICALS A/S (CVR 30082346) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 0 and a net result of DKK -9,883,156 compared with DKK -1,504,899 the year before. Equity in the 2021 report amounted to DKK 27,371,235. The solvency ratio was 95.3%.
- Revenue
- DKK 0
- Gross Profit
- DKK 0
- Profit/Loss
- DKK -9,883,156
- Equity
- DKK 27,371,235
- Total Assets
- DKK 28,708,175
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | 0 | 0 | -9.9M | 27.4M | - |
| 2020 | 0 | 0 | -1.5M | 13.4M | - |
| 2019 | 0 | 0 | -1.9M | 14.9M | - |
| 2018 | 0 | 0 | -1.3M | 2.4M | - |
| 2017 | - | -1.3M | -1.6M | 3.7M | - |
Official annual report
Find more companies like REPONEX PHARMACEUTICALS A/S
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
As of October 14, 2021, Katrine Hoff Schlichtkrull has left the board of directors of REPONEX PHARMACEUTICALS A/S.
REPONEX PHARMACEUTICALS A/S has published its annual report for 2020. Revenue came to DKK 0, and the net result was DKK -1,504,899.
As of June 22, 2021, Troels Peter Troelsen has joined the board of directors of REPONEX PHARMACEUTICALS A/S.
As of June 22, 2021, Katrine Hoff Schlichtkrull has joined the board of directors of REPONEX PHARMACEUTICALS A/S.
As of June 22, 2021, Christian Vinding Thomsen has joined the board of directors of REPONEX PHARMACEUTICALS A/S.
As of June 21, 2021, Troels Peter Troelsen has left the board of directors of REPONEX PHARMACEUTICALS A/S.
As of March 1, 2021, Klaus Snej Jensen is registered as adm. dir. of REPONEX PHARMACEUTICALS A/S.
As of March 1, 2021, Torsten Bjørn has stepped down as director of REPONEX PHARMACEUTICALS A/S.
About REPONEX PHARMACEUTICALS A/S
REPONEX PHARMACEUTICALS A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2006. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named REPONEX PHARMACEUTICALS ApS and TRIFOILIUM ApS. The management consists of Christian Henrik Tange. The board consists of Christian Vinding Thomsen (chair), Troels Peter Troelsen and Charlotte Pahl. The company is owned by Pharma Equity Group A/S. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 0 and a net result of DKK -6,570,000 compared with DKK -11,943,000 the year before. Equity in the 2025 report amounted to DKK 4,645,000.